Elite Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Elite Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 100% to $56,625,128. The net income dropped to $20,108,631 and profit margin reached 36%. Total operating expenses were $15,568,334.
Profit Margin
| 2015 | 5.01M | 28.92M | 576.83% |
|---|---|---|---|
| 2016 | 12.49M | -683.01K | -5.46% |
| 2017 | 9.63M | 3.81M | 39.54% |
| 2018 | 7.45M | -3.67M | -49.25% |
| 2019 | 7.56M | -9.27M | -122.6% |
| 2020 | 17.99M | -2.24M | -12.45% |
| 2021 | 25.38M | 5.08M | 20.05% |
| 2022 | 32.26M | 8.89M | 27.58% |
| 2023 | 34.15B | 4.40B | 12.91% |
| 2024 | 56.62M | 20.10M | 35.51% |
ELTP Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 56.62M | 34.15B | 32.26M | 25.38M | 17.99M | 7.56M | 7.45M | 9.63M | 12.49M | 5.01M |
Cost of revenue | 30.26M | 17.56B | 17.46M | 13.51M | 10.01M | 4.70M | 3.51M | 5.89M | 4.48M | 3.01M |
Gross profit | 26.35M | 16.59B | 14.79M | 11.86M | 7.97M | 2.86M | 3.94M | 3.73M | 8.01M | 2.00M |
Operating exp. | ||||||||||
Research and development | 6.88M | 6.20B | 4.05M | 5.11M | 5.53M | 7.59M | 9.62M | 8.30M | 12.42M | 14.72M |
Selling and marketing | 340.12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 15.56M | 12.91B | 9.72M | 9.76M | 10.26M | 12.02M | 12.99M | 11.09M | 16.33M | 18.50M |
Operating income | 10.78M | 2.02B | 5.07M | 2.10M | -2.28M | -9.15M | -9.05M | -7.35M | -8.31M | -16.50M |
Other income (expenses), net | -10.32M | 309.87K | 1.23M | 2.03M | 47.05K | -448.92K | 4.65M | 9.29M | 7.39M | 21.72M |
Income before tax | 463.09K | 3.98B | 6.30M | 4.14M | -2.23M | -9.95M | -4.71M | 1.94M | -1.20M | 28.92M |
Income tax expense | -19.64M | -424.02M | -1.73M | -943.90K | 2K | -427.46K | -710.33K | -1.62M | -520.45K | -3.24K |
Net income | 20.10M | 4.40B | 8.89M | 5.08M | -2.24M | -9.27M | -3.67M | 3.81M | -683.01K | 28.92M |
Earnings per share | ||||||||||
Basic EPS | 0.01 | 4.35 | 0.00 | 0.00 | -0.00 | -0.01 | -0.00 | 0.03 | -0.00 | 0.05 |
Diluted EPS | 0.01 | 4.35 | 0.00 | 0.00 | -0.00 | -0.01 | -0.00 | -0.01 | -0.00 | -0.02 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |